Investment Summary |
|
|---|---|
| Date | 2013-05-31 |
| Target | Epizyme |
| Sector | Life Science |
| Investor(s) | Bay City Capital |
| Sellers(s) | Bay City Capital |
| Deal Type | PIPE |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 68 of 75 |
| Sector (Life Science) | 49 of 54 |
| Type (PIPE) | 3 of 4 |
| State (Massachusetts) | 8 of 10 |
| Country (United States) | 65 of 72 |
| Year (2013) | 4 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-22 |
Interleukin Genetics
Waltham, Massachusetts, United States Interleukin Genetics, Inc. is a genetics-based personalized health company that develops genetic tests for use in the emerging personalized health market. Our vision is to build a leading personalized health and wellness company. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-14 |
Conatus Pharmaceuticals
San Diego, California, United States Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Conatus Pharmaceuticals was founded in 2005 and is based in San Diego, California. |
Sell | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 44 of 62 |
| Sector (Life Science) | 30 of 45 |
| Type (PIPE) | 1 of 1 |
| State (Massachusetts) | 4 of 8 |
| Country (United States) | 42 of 59 |
| Year (2013) | 4 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-22 |
Interleukin Genetics
Waltham, Massachusetts, United States Interleukin Genetics, Inc. is a genetics-based personalized health company that develops genetic tests for use in the emerging personalized health market. Our vision is to build a leading personalized health and wellness company. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-14 |
Conatus Pharmaceuticals
San Diego, California, United States Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Conatus Pharmaceuticals was founded in 2005 and is based in San Diego, California. |
Sell | - |
